𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Solid-state characterization of mefenamic acid

✍ Scribed by Ramesh Panchagnula; Prakash Sundaramurthy; Omathanu Pillai; Shrutidevi Agrawal; Yasvanth Ashok Raj


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
484 KB
Volume
93
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis


The purpose of this study was to characterize mefenamic acid (MA) from commercial samples and samples crystallized from different solvents. Various techniques used for characterization included microscopy (hot stage microscopy, scanning electron microscopy), intrinsic dissolution rate, differential scanning calorimetry (DSC), Fourier transform infrared (FTIR) spectroscopy and powder X-ray diffractometry (pXRD). The commercial samples varied in their crystal habit, thermal behavior, and intrinsic dissolution rate. It was found that the commercial samples were polymorphic Form I, which converted to Form II on heating in a DSC pan. Similarly, compression in an intrinsic dissolution rate (IDR) press resulted in the conversion of Form I to Form II. On the other hand, the samples recrystallized from different solvents under varying conditions yielded different crystal habits. Stirring and degree of supersaturation significantly influenced the crystal habit in all the solvents used in the study. Samples crystallized from ethanol and tetrahydrofuran yielded Form I, which behaved similarly to the commercial samples (M1 and M3). Recrystallization from ethyl acetate at a fast cooling rate yielded Form I, which on melting crystallized to Form II. The form I crystallized from ethyl acetate by fast cooling converted partially to form II on storing at ambient conditions. Forms I and II of MA were enantiotropically related. The results demonstrate the variable material characteristics of the commercial samples of MA and the influence of the crystallizing conditions on the formation of the polymorphs.


πŸ“œ SIMILAR VOLUMES


Physicochemical and crystallographic cha
✍ Liang Fang; Sachihiko Numajiri; Daisuke Kobayashi; Hideo Ueda; Koji Nakayama; Hi πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 348 KB

The preparation of mefenamic acid (MH)-alkanolamine (propanolamine, diethanolamine, triethanolamine) complexes was attempted to increase the transdermal flux of MH. Differential scanning calorimetry, Fourier transform infrared spectroscopy, and X-ray crystallographic studies demonstrated that MH and

Crystallization of mefenamic acid and po
✍ S. Cesur; S. Gokbel πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 192 KB

## Abstract The crystallization of Mefenamic Acid, (MA), which has a prevalent usage in drug formulation, was investigated. MA is a high‐dose, anti‐inflammatory, analgesic agent used for pain in menstrual disorders. Some negative properties of MA are a high hydrophobicity and propensity to stick to

Identification and characterization of s
✍ Quan He; Jesse Zhu; Hassan Gomaa; Michael Jennings; Sohrab Rohani πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 316 KB

The racemate and enantiomers of 2-chloromandelic acid were characterized by SS-NMR, XRPD, and FTIR. The binary melting point phase diagram was constructed by DSC (differential scanning calorimetry). The solid-state nature of 2-chloromandelic acid was identified to be a racemic compound. The crystal

Solid-state characterization of a novel
✍ A. Marini; V. Berbenni; G. Bruni; A. Maggioni; P. Cofrancesco; C. Sinistri; A. O πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 311 KB

We present the results of a thermal, spectroscopic, diffractometric, and microscopic study of a novel DNA intercalator synthesized by Novuspharma S.p.A. (code name BRR 2778, purity by high-performance liquid chromatography: 99.4%). We found that the form that is stable at room temperature contains 1

Quantitative evaluation of mefenamic aci
✍ Makoto Otsuka; Jun-ichi Nishizawa; Jiro Shibata; Masahiko Ito πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 278 KB

The purpose of the present study is to measure polymorphic content in a bulk powder, mefenamic acid polymorph of pharmaceuticals, as a model drug by THz-spectrometer using frequency-tunable THz wave generators based on difference-frequency generation in gallium phosphate crystals. Mefenamic acid pol